Agios Pharmaceuticals AGIO Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $35.75M.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's total debt?
- Agios Pharmaceuticals (AGIO) reported total debt of $35.75M in Q1 2026.
- How has Agios Pharmaceuticals's total debt changed year-over-year?
- Agios Pharmaceuticals's total debt decreased by 32.5% year-over-year, from $52.94M to $35.75M.
- What is the long-term trend for Agios Pharmaceuticals's total debt?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's total debt has grown at a -17.5% compound annual growth rate (CAGR), from $105.2M to $40.21M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.